US · Healthcare

Coeptis Therapeutics Holdings Inc (COEPW)

Biotechnology

Coeptis Therapeutics Holdings Inc (COEPW) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for COEPW

P/E ratio

18.00

Coeptis Therapeutics Holdings Inc (COEPW) — FAQ

What is COEPW's P/E ratio?

The price-to-earnings (P/E) ratio for Coeptis Therapeutics Holdings Inc (COEPW) is 18.00 (data as of 2026-03-24).

Does Coeptis Therapeutics Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for Coeptis Therapeutics Holdings Inc (COEPW). Check the MyAverix Finance app for the latest dividend data.

What sector is Coeptis Therapeutics Holdings Inc in?

Coeptis Therapeutics Holdings Inc (COEPW) is classified in the Healthcare sector (Biotechnology industry).

What exchange is COEPW listed on?

COEPW is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)